VERASTEM INC (VSTM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VSTM • US92337C2035

6.28 USD
-0.37 (-5.56%)
At close: Feb 10, 2026
6.49 USD
+0.21 (+3.34%)
After Hours: 2/10/2026, 6:31:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, VSTM scores 1 out of 10 in our fundamental rating. VSTM was compared to 523 industry peers in the Biotechnology industry. VSTM has a bad profitability rating. Also its financial health evaluation is rather negative. VSTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VSTM has reported negative net income.
  • VSTM had a negative operating cash flow in the past year.
  • VSTM had negative earnings in each of the past 5 years.
  • In the past 5 years VSTM always reported negative operating cash flow.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • The Return On Assets of VSTM (-73.87%) is worse than 63.86% of its industry peers.
Industry RankSector Rank
ROA -73.87%
ROE N/A
ROIC N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • VSTM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VSTM has more shares outstanding than it did 1 year ago.
  • VSTM has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VSTM is higher compared to a year ago.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -8.81, we must say that VSTM is in the distress zone and has some risk of bankruptcy.
  • VSTM has a Altman-Z score of -8.81. This is in the lower half of the industry: VSTM underperforms 69.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.81
ROIC/WACCN/A
WACC12.54%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 2.58 indicates that VSTM has no problem at all paying its short term obligations.
  • The Current ratio of VSTM (2.58) is worse than 69.41% of its industry peers.
  • A Quick Ratio of 2.55 indicates that VSTM has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.55, VSTM is not doing good in the industry: 67.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.55
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • VSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.00%.
  • VSTM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.55% yearly.
EPS 1Y (TTM)-21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%N/A

3.2 Future

  • VSTM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.78% yearly.
  • Based on estimates for the next years, VSTM will show a very strong growth in Revenue. The Revenue will grow by 121.18% on average per year.
EPS Next Y8.17%
EPS Next 2Y20.64%
EPS Next 3Y18.97%
EPS Next 5Y18.78%
Revenue Next Year237.98%
Revenue Next 2Y244.62%
Revenue Next 3Y192.14%
Revenue Next 5Y121.18%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • VSTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VSTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VSTM's earnings are expected to grow with 18.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.64%
EPS Next 3Y18.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VSTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERASTEM INC

NASDAQ:VSTM (2/10/2026, 6:31:13 PM)

After market: 6.49 +0.21 (+3.34%)

6.28

-0.37 (-5.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)03-18
Inst Owners77.99%
Inst Owner Change-0.89%
Ins Owners0.39%
Ins Owner Change1.18%
Market Cap484.50M
Revenue(TTM)10.00M
Net Income(TTM)-130.64M
Analysts85.33
Price Target16.45 (161.94%)
Short Float %23.56%
Short Ratio8.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.89%
Min EPS beat(2)-108.2%
Max EPS beat(2)48.42%
EPS beat(4)1
Avg EPS beat(4)-32.54%
Min EPS beat(4)-108.2%
Max EPS beat(4)48.42%
EPS beat(8)3
Avg EPS beat(8)-15.88%
EPS beat(12)6
Avg EPS beat(12)-9.72%
EPS beat(16)8
Avg EPS beat(16)-6.19%
Revenue beat(2)2
Avg Revenue beat(2)90.77%
Min Revenue beat(2)86.8%
Max Revenue beat(2)94.73%
Revenue beat(4)2
Avg Revenue beat(4)-4.62%
Min Revenue beat(4)-100%
Max Revenue beat(4)94.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)4.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)63.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 48.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.86
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS0.13
BVpS-0.2
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1894.51%
Cap/Sales 82.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.55
Altman-Z -8.81
F-Score2
WACC12.54%
ROIC/WACCN/A
Cap/Depr(3y)35.9%
Cap/Depr(5y)41.04%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y8.17%
EPS Next 2Y20.64%
EPS Next 3Y18.97%
EPS Next 5Y18.78%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%N/A
Revenue Next Year237.98%
Revenue Next 2Y244.62%
Revenue Next 3Y192.14%
Revenue Next 5Y121.18%
EBIT growth 1Y-24.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5Y36.99%
FCF growth 1Y-92.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-80.75%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 1 / 10 to VSTM.


What is the valuation status for VSTM stock?

ChartMill assigns a valuation rating of 0 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


What is the profitability of VSTM stock?

VERASTEM INC (VSTM) has a profitability rating of 0 / 10.


What is the financial health of VERASTEM INC (VSTM) stock?

The financial health rating of VERASTEM INC (VSTM) is 2 / 10.